×

Raymond James: Abbvie has value-enhancing catalysts

12:30 PM ET Fri, 2 Sept 2016

Chris Raymond, Raymond James managing director and senior biotech analyst, shares his bullish take on Abbvie. The "Fast Money Halftime Report" traders and Barbara Doran, Yorkbridge director and senior portfolio manager, weigh in.